Skip to main content
Clinical Trials/NCT01285193
NCT01285193
Unknown
Not Applicable

A Randomized Controlled Trial to Treat Hypertension by Regularising and Slowing Breathing

Penang Hospital, Malaysia1 site in 1 country84 target enrollmentJune 2011
ConditionsHypertension

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
Penang Hospital, Malaysia
Enrollment
84
Locations
1
Primary Endpoint
Diastolic blood pressure
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study is to determine if blood pressure can be reduced in hypertensive subjects by regularising and slowing their breathing. This may be a safe and affordable complementary treatment for hypertension.

Detailed Description

This is a randomised controlled trial in which hypertensive subjects allocated to receive either a CD with relaxation music or one with the same music plus certain sound cues to guide the listener on when to breathe. The subjects will continue with their normal medications and the intervention will last 2 months.

Registry
clinicaltrials.gov
Start Date
June 2011
End Date
February 2012
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Penang Hospital, Malaysia

Eligibility Criteria

Inclusion Criteria

  • Above 18 years old
  • Patients with essential hypertension
  • Systolic BP from 140 to 159 mm Hg
  • Diastolic BP from 90 to 99 mm Hg
  • On hypertensive medication for at least 3 months before the study
  • Hypertensive medication unchanged during the 3 months before the study
  • Patients able to fill in a log sheet

Exclusion Criteria

  • ischaemic heart disease
  • congestive heart failure
  • cardiac arrhythmias
  • renal failure
  • diabetes mellitus
  • previous stroke
  • major organ failure
  • cigarette smoking
  • respiratory diseases
  • psychiatric disorders

Outcomes

Primary Outcomes

Diastolic blood pressure

Time Frame: 2 months

Change in diastolic blood pressure from baseline to end value at 2 months.

Secondary Outcomes

  • Systolic blood presure(2 months)

Study Sites (1)

Loading locations...

Similar Trials